The latest price target for Theratechnologies (NASDAQ:THTX) was reported by JonesTrading on July 17, 2023. The analyst firm set a price target for $3.00 expecting THTX to rise to within 12 months (a possible 112.75% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Theratechnologies (NASDAQ:THTX) was provided by JonesTrading, and Theratechnologies maintained their buy rating.

There is no last upgrade for Theratechnologies

The last downgrade for Theratechnologies Inc happened on July 29, 2021 when Canaccord Genuity changed their price target from $8 to $3 for Theratechnologies Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Theratechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Theratechnologies was filed on July 17, 2023 so you should expect the next rating to be made available sometime around July 17, 2024.

While ratings are subjective and will change, the latest Theratechnologies (THTX) rating was a maintained with a price target of $6.00 to $3.00. The current price Theratechnologies (THTX) is trading at is $1.41, which is out of the analyst’s predicted range.